LPL Financial’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $299K | Sell |
6,338
-2,509
| -28% | -$118K | ﹤0.01% | 4669 |
|
|
2025
Q1 | $346K | Buy |
8,847
+701
| +9% | +$27.4K | ﹤0.01% | 4388 |
|
|
2024
Q4 | $441K | Buy |
8,146
+1,332
| +20% | +$72.1K | ﹤0.01% | 4136 |
|
|
2024
Q3 | $344K | Buy |
6,814
+319
| +5% | +$16.1K | ﹤0.01% | 4236 |
|
|
2024
Q2 | $286K | Sell |
6,495
-151
| -2% | -$6.64K | ﹤0.01% | 4227 |
|
|
2024
Q1 | $334K | Sell |
6,646
-620
| -9% | -$31.1K | ﹤0.01% | 4055 |
|
|
2023
Q4 | $439K | Buy |
7,266
+404
| +6% | +$24.4K | ﹤0.01% | 3721 |
|
|
2023
Q3 | $391K | Buy |
6,862
+767
| +13% | +$43.7K | ﹤0.01% | 3648 |
|
|
2023
Q2 | $311K | Buy |
+6,095
| New | +$311K | ﹤0.01% | 3774 |
|